Back
Cullinan Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
CGEM
Cullinan Therapeutics, Inc.
Last Price:
$10.18
Seasonality Move:
11%
7 Day Trial
ALL ACCESS PASS
$
7
Cullinan Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Cullinan Therapeutics, Inc. has on average historically fallen by 7.6% based on the past 4 years of stock performance.
-
Cullinan Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Cullinan Therapeutics, Inc. Stock Undervalued?The current Cullinan Therapeutics, Inc. [CGEM] share price is $9.68. The Score for CGEM is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
CGEM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Cullinan Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Cullinan Therapeutics, Inc. has on average historically fallen by 7.6% based on the past 4 years of stock performance.
Cullinan Therapeutics, Inc. Stock Rating
Sell
42
Cullinan Therapeutics, Inc. (CGEM)
is a Sell
Is Cullinan Therapeutics, Inc. overpriced?
-
Cullinan Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Cullinan Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cullinantherapeutics.com
52-Week Data
52-Week High:
13.33
52-Week Low:
5.68
Prediction Charts
Market Cap:
571.9M
Price in USD:
9.68
Volume:
1.9M
Beta:
-0.10
Technical Analysis
SMA50:
9.26
SMA100:
8.10
SMA200:
8.09
52-Wk Change:
-11.6%
Stock Predictions
-
Is Cullinan Therapeutics, Inc. stock public?Yes, Cullinan Therapeutics, Inc. is a publicly traded company.
-
What is the Cullinan Therapeutics, Inc. stock quote today?The Cullinan Therapeutics, Inc. stock price is 9.68 USD today.
-
How to buy Cullinan Therapeutics, Inc. stock online?You can buy Cullinan Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 10.73 | 10.20 | 11.15 | 10.13 |
| Dec-3 | 10.18 | 10.50 | 10.68 | 10.01 |
| Dec-4 | 10.43 | 10.58 | 10.79 | 10.08 |
| Dec-5 | 10.69 | 10.59 | 10.80 | 10.28 |
| Dec-8 | 10.89 | 12.44 | 12.71 | 10.56 |
| Dec-9 | 12.44 | 12.36 | 12.88 | 11.90 |
| Dec-10 | 12.77 | 12.46 | 12.85 | 12.11 |
| Dec-11 | 12.45 | 12.38 | 13.10 | 12.04 |
| Dec-12 | 12.38 | 11.92 | 12.94 | 11.90 |
| Dec-15 | 11.90 | 10.82 | 12.09 | 10.76 |
| Dec-16 | 10.96 | 10.22 | 11.23 | 10.08 |
| Dec-17 | 10.20 | 9.59 | 10.37 | 9.48 |
| Dec-18 | 9.67 | 9.98 | 10.09 | 9.60 |
| Dec-19 | 10.10 | 9.68 | 10.14 | 9.61 |
Cullinan Therapeutics, Inc. Earnings
Cullinan Therapeutics, Inc. Earnings Report: Per Share Cullinan Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cullinan Therapeutics, Inc. Forecast Revenue Growth
Cullinan Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Cullinan Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.67 per share, and an increase next year of $0.29 per share.
* Cullinan Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.